A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Insulin degludec/insulin aspart (Primary) ; Insulin aspart; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 May 2012 New trial record